Showing 37 to 48 of 100 results
Biden Diagnosed with Aggressive Prostate Cancer
Former President Joe Biden has been diagnosed with a Gleason 9 (Grade Group 5) prostate cancer with bone metastasis, prompting immediate treatment planning; this aggressive, yet hormone-sensitive cancer follows the discovery of a prostate nodule after increasing urinary symptoms.
Biden Diagnosed with Aggressive Prostate Cancer
Former President Joe Biden has been diagnosed with a Gleason 9 (Grade Group 5) prostate cancer with bone metastasis, prompting immediate treatment planning; this aggressive, yet hormone-sensitive cancer follows the discovery of a prostate nodule after increasing urinary symptoms.
Progress
24% Bias Score
Biden's Advanced Prostate Cancer Diagnosis Spurs Global Concern
Former President Joe Biden has been diagnosed with stage five prostate cancer that has spread to his bones, prompting global concern and highlighting the importance of early detection for this common but treatable disease.
Biden's Advanced Prostate Cancer Diagnosis Spurs Global Concern
Former President Joe Biden has been diagnosed with stage five prostate cancer that has spread to his bones, prompting global concern and highlighting the importance of early detection for this common but treatable disease.
Progress
40% Bias Score
Biden Diagnosed with Aggressive Prostate Cancer
President Biden, 82, has been diagnosed with an aggressive form of prostate cancer with bone metastasis; former Presidents Obama, Clinton, and Trump offered support and well wishes.
Biden Diagnosed with Aggressive Prostate Cancer
President Biden, 82, has been diagnosed with an aggressive form of prostate cancer with bone metastasis; former Presidents Obama, Clinton, and Trump offered support and well wishes.
Progress
32% Bias Score
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
Progress
24% Bias Score
Improved Autism Diagnosis, Not a Rising Epidemic
The perceived increase in autism diagnoses stems from improved detection methods and societal understanding, not necessarily a higher incidence; genetic factors play a significant role, but support systems for those diagnosed remain inadequate.
Improved Autism Diagnosis, Not a Rising Epidemic
The perceived increase in autism diagnoses stems from improved detection methods and societal understanding, not necessarily a higher incidence; genetic factors play a significant role, but support systems for those diagnosed remain inadequate.
Progress
60% Bias Score
Eightfold Increase in UK Autism Diagnoses Linked to Broader Criteria
A new study shows an eightfold increase in autism diagnoses in the UK between 1998 and 2018, driven by broader diagnostic criteria, increased awareness, and better understanding of autism's presentation in females and adults, rather than a genuine surge in autism prevalence.
Eightfold Increase in UK Autism Diagnoses Linked to Broader Criteria
A new study shows an eightfold increase in autism diagnoses in the UK between 1998 and 2018, driven by broader diagnostic criteria, increased awareness, and better understanding of autism's presentation in females and adults, rather than a genuine surge in autism prevalence.
Progress
36% Bias Score
Biden Diagnosed with Aggressive, but Treatable, Prostate Cancer
President Biden, 82, was diagnosed with hormone-sensitive prostate cancer (Gleason score 9) that has metastasized to the bone; his team is reviewing treatment options.
Biden Diagnosed with Aggressive, but Treatable, Prostate Cancer
President Biden, 82, was diagnosed with hormone-sensitive prostate cancer (Gleason score 9) that has metastasized to the bone; his team is reviewing treatment options.
Progress
28% Bias Score
Biden Announces Advanced Prostate Cancer Diagnosis
President Biden, 82, announced a diagnosis of hormone-sensitive prostate cancer that has spread to his bones; his office confirmed this on Sunday, with Biden making a public statement on Monday. Treatment options are being explored, and he is receiving bipartisan support.
Biden Announces Advanced Prostate Cancer Diagnosis
President Biden, 82, announced a diagnosis of hormone-sensitive prostate cancer that has spread to his bones; his office confirmed this on Sunday, with Biden making a public statement on Monday. Treatment options are being explored, and he is receiving bipartisan support.
Progress
44% Bias Score
Tanzanian Woman's Decade-Long Battle with Lupus Highlights Diagnostic Challenges
A Tanzanian woman, Hajjrat Mohammed, shares her arduous journey battling Lupus, a debilitating autoimmune disease, highlighting diagnostic challenges and the urgent need for increased awareness and support in Tanzania.
Tanzanian Woman's Decade-Long Battle with Lupus Highlights Diagnostic Challenges
A Tanzanian woman, Hajjrat Mohammed, shares her arduous journey battling Lupus, a debilitating autoimmune disease, highlighting diagnostic challenges and the urgent need for increased awareness and support in Tanzania.
Progress
48% Bias Score
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
Progress
36% Bias Score
Inside Our ADHD Minds": Challenging Misconceptions and Promoting Understanding of ADHD
Chris Packham's "Inside Our ADHD Minds" explores ADHD through expert interviews and personal stories, challenging the common understanding of the condition and highlighting the impact of gendered diagnostic biases and societal misunderstandings.
Inside Our ADHD Minds": Challenging Misconceptions and Promoting Understanding of ADHD
Chris Packham's "Inside Our ADHD Minds" explores ADHD through expert interviews and personal stories, challenging the common understanding of the condition and highlighting the impact of gendered diagnostic biases and societal misunderstandings.
Progress
20% Bias Score
Faster Meningitis Diagnosis Saves Lives
Amsterdam UMC researchers created a rapid test to distinguish between bacterial and viral meningitis, reducing diagnosis time from two days to under an hour, significantly improving treatment speed for life-threatening bacterial infections.
Faster Meningitis Diagnosis Saves Lives
Amsterdam UMC researchers created a rapid test to distinguish between bacterial and viral meningitis, reducing diagnosis time from two days to under an hour, significantly improving treatment speed for life-threatening bacterial infections.
Progress
36% Bias Score
Showing 37 to 48 of 100 results